echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > A major discovery: all cancer types can be divided into two types according to whether YAP protein is expressed or not

    A major discovery: all cancer types can be divided into two types according to whether YAP protein is expressed or not

    • Last Update: 2021-08-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Written | Edited by Wang Cong | Typesetting by Wang Duoyu | Yes-Associated Protein (Yes-Associated Protein), a core effector of the Hippo signaling pathway, is a multifunctional intracellular connexin and transcriptional co-activator, in normal organisms The cell plays a role in signal transduction and gene transcription regulation
    .

    Many studies have shown that YAP is involved in tumorigenesis and development, and plays the role of oncogene in the body.
    Increased expression and activity of YAP can promote malignant transformation of cells
    .

    On July 15, 2021, researchers from Mount Sinai Hospital in Toronto and the University of Toronto published a research paper titled Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity in Cancer Cell
    .

    The study showed that all cancers can be divided into two categories based on the presence or absence of YAP protein.
    This discovery provides a new strategy for the treatment of the most aggressive and incurable types of cancer
    .

    As an important regulator and effector of the Hippo signaling pathway, YAP plays an important role in the formation of malignant tumors.
    YAP exists in all cancers, regardless of whether its expression is turned on or off
    .

    This is related to its drug sensitivity or drug resistance
    .

    When culturing cancer cells in the laboratory, the cancer cells are either suspended or adherent, and YAP is its main regulator.
    All suspended cancer cells are YAP expression turned off (YAPoff), and all adherent cells They are all turned on by YAP expression (YAPon).
    This change in cell adhesion behavior is related to drug resistance and invasiveness, which indicates that YAP is the key to this change in drug resistance and malignant transformation
    .

    In cancer cells, the closing or opening of YAP has the opposite effect of promoting or suppressing cancer.
    For YAPon cancer, the presence of YAP is required to grow and survive, while for YAPoff cancer, the presence of YAP can inhibit cancer cell growth
    .

    The research team also found that YAPoff cancers are usually highly lethal, such as retinoblastoma, small cell lung cancer, and neuroendocrine prostate cancer
    .

    Some cancers such as prostate cancer and lung cancer can also transition from YAPon state to YAPoff state to resist treatment
    .

    Therefore, the method of preventing this YAP state transition can be an effective method of preventing drug resistance
    .

    In general, this study shows that all cancers can be divided into two categories based on the presence or absence of YAP protein-YAPon cancer and YAPoff cancer
    .

    This simple binary classification may have a profound impact on cancer treatment, and can be used to infer the vulnerability of cancer, develop new therapies, and improve the effectiveness of cancer treatment
    .

    Link to the paper: https://doi.
    org/10.
    1016/j.
    ccell.
    2021.
    06.
    016E Pharmaceutical World, a sister number launched by Biological World, focuses on industrialization reports and excavations in the pharmaceutical field, focusing on gene therapy, cell therapy, and antibody drugs And other fields, welcome to pay attention
    .

    Click on the card below to view and follow Open Reprint This article Open Reprint: Just leave a message in this article and let us know
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.